Tap Pharmaceutical, Fujisawa deal

Tap, a joint venture between Abbott Laboratories (ABT, Abbott Park, Ill.) and Takeda Chemicals Ltd. (Osaka, Japan), licensed exclusive rights from Fujisawa to develop FR229934, a phosphodiesterase ty...